Decreased concentrations of the lipoprotein lipase inhibitor angiopoietin-like protein 4 and increased serum triacylglycerol are associated with increased neonatal fat mass in pregnant women with gestational diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 8, 2013, Pages 3430-3437

  Ortega Senovilla, Henar ^a   Schaefer Graf, Ute ^b   Meitzner, Katrin ^b   Abou Dakn, Michael ^b   Herrera, Emilio ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b St Joseph Hospital Berlin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN LIKE PROTEIN 4; FATTY ACID; GLUCOSE; INSULIN; LIPOPROTEIN LIPASE; PHOSPHOLIPASE INHIBITOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; FAT MASS; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; NEWBORN; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; UMBILICAL CORD BLOOD; VAGINAL DELIVERY;

ADIPOSE TISSUE; ADULT; ANGIOPOIETINS; BODY COMPOSITION; DIABETES, GESTATIONAL; FEMALE; HUMANS; INFANT, NEWBORN; LIPOPROTEIN LIPASE; PREGNANCY; TRIGLYCERIDES;

EID: 84881510592     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1614     Document Type: Article

References (35)

1. Jansson T, Cetin I, Powell TL, Desoye G, Radaelli T, Ericsson A, Sibley CP. Placental transport and metabolism in fetal overgrowth: a workshop report. Placenta. 2006;27:S109-S113.
2. Widdowson EM. Growth and composition of the fetus and newborn. In: Assali NS, ed. Biology of Gestation. New York, NY: Academic Press; 1968:1-49.
3. Herrera E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine. 2002;19:43-55.
4. Bonet B, Brunzell JD, Gown AM, Knopp RH. Metabolism of verylow-density lipoprotein triglyceride by human placental cells: the role of lipoprotein lipase. Metabolism. 1992;41:596-603.
5. Waterman IJ, Emmison N, Dutta-Roy AK. Characterisation of triacylglycerol hydrolase activities in human placenta. Biochim Biophys Acta. 1998;1394:169-176.
6. Lasuncion MA, Herrera E. "In vitro" utilization of labelled esterified fatty acids and glyceride glycerol from triglyceride-rich lipoproteins in rat adipose tissue. Horm Metab Res. 1981;13:335-339.
7. Lasuncion MA, Herrera E. Changes with starvation in the rat of the lipoprotein lipase activity and hydrolysis of triacylglycerols from triacylglycerol-rich lipoproteins in adipose tissue preparations. Biochem J. 1983;210:639-643.
8. Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab. 2004;89:4607-4614.
9. Magnusson-Olsson AL, Hamark B, Ericsson A, Wennergren M, Jansson T, Powell TL. Gestational and hormonal regulation of human placental lipoprotein lipase. J Lipid Res. 2006;47:2551-2561.
10. Petersen S, Gotfredsen A, Knudsen FU. Lean body mass in small for gestational age and appropriate for gestational age infants. J Pediatr. 1988;113:886-889.
11. Lindegaard ML, Damm P, Mathiesen ER, Nielsen LB. Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression. J Lipid Res. 2006;47:2581-2588.
12. Kersten S. Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans. 2005;33:1059-1062.
13. Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med. 2008;18: 6-14.
14. Miida T, Hirayama S. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Curr Opin Lipidol. 2010;21:70-75.
15. Shan L, Yu XC, Liu Z, et al. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J Biol Chem. 2009;284:1419-1424.
16. Sukonina V, Lookene A, Olivecrona T, Olivecrona G. Angiopoietinlike protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci USA. 2006;103:17450-17455.
17. Romeo S, Yin W, Kozlitina J, et al. Rare loss-of-function mutations inANGPTLfamily members contribute to plasma triglyceride levels in humans. J Clin Invest. 2009;119:70-79.
18. Desai U, Lee EC, Chung K, et al. Lipid-lowering effects of antiangiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc Natl Acad Sci USA. 2007;104:11766-11771.
19. Koster A, Chao YB, Mosior M, et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology. 2005;146:4943-4950.
20. Herrera E, Lasuncion MA, Gomez-Coronado D, Aranda P, Lopez-Luna P, Maier I. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am J Obstet Gynecol. 1988;158:1575-1583.
21. Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009;32:1076-1080.
22. Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, et al. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med. 2011;28:1053-1059.
23. Schaefer-Graf UM, Graf K, Kulbacka I, et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care. 2008;31:1858-1863.
24. Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, et al. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care. 2011;34:2061-2066.
25. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768-773.
26. Catalano PM, Tyzbir ED, Allen SR, McBean JH, McAuliffe TL. Evaluation of fetal growth by estimation of neonatal body composition. Obstet Gynecol. 1992;79:46-50.
27. Yoshida K, Shimizugawa T, Ono M, Furukawa H. Angiopoietinlike protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res. 2002;43:1770-1772.
28. Herrera E, Ortega-Senovilla H. Maternal lipid metabolism during normal pregnancy and its implications to fetal development. Clin Lipidol. 2010;5:899-911.
29. Montelongo A, Lasuncion MA, Pallardo LF, Herrera E. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes. 1992;41:1651-1659.
30. Herrera E, Ortega H, Alvino G, Giovannini N, Amusquivar E, Cetin I. Relationship between plasma fatty acid profile and antioxidant vitamins during normal pregnancy. Eur J Clin Nutr. 2004;58:1231-1238.
31. Kersten S, Lichtenstein L, Steenbergen E, et al. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol. 2009;29:969-974.
32. Jonker JT, Smit JW, Hammer S, et al. Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes. Am J Clin Nutr. 2013;97:255-260.
33. Kim I, Kim HG, Kim H, et al. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J. 2000;346:603-610.
34. Taricco E, Radaelli T, Nobile de Santis MS, Cetin I. Foetal and placental weights in relation to maternal characteristics in gestational diabetes. Placenta. 2003;24:343-347.
35. van Aerde JE, Wilke MS, Feldman M, Clandinin MT. Accretion of lipid in the fetus and newborn. In: Polin RA, Fox WW, Abman SH, eds. Fetal and Neonatal Physiology. Philadelphia: Elsevier; 2011:454-470.